Literature DB >> 15767449

The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter.

Rongsheng Peng1, Stephanie C Moses, Jie Tan, Elisabeth Kremmer, Paul D Ling.   

Abstract

The mechanistic contribution of the Epstein-Barr virus (EBV) EBNA-LP protein to B-cell immortalization remains an enigma. However, previous studies have indicated that EBNA-LP may contribute to immortalization by enhancing EBNA2-mediated transcriptional activation of the LMP-1 gene. To gain further insight into the potential role EBNA-LP has in EBV-mediated B-cell immortalization, we asked whether it is a global or gene-specific coactivator of EBNA2 and whether coactivation requires interaction between these proteins. In type I Burkitt's lymphoma cells, we found that EBNA-LP strongly coactivated EBNA2 stimulation of LMP-1 and LMP2B RNAs, which are expressed from the viral divergent promoter. Surprisingly, the viral LMP2A gene and cellular CD21 and Hes-1 genes were induced by EBNA2 but showed no further induction after EBNA-LP coexpression. We also found that EBNA-LP did not stably interact with EBNA2 in coimmunoprecipitation assays, even though the conditions were adequate to observe specific interactions between EBNA2 and its cellular cofactor, CBF1. Colocalization between EBNA2 and EBNA-LP was not detectable in EBV-transformed cell lines or transfected type I Burkitt's cells. Finally, no significant interactions between EBNA2 and EBNA-LP were found with mammalian two-hybrid assays. From this data, we conclude that EBNA-LP is not a global coactivator of EBNA2 targets, but it preferentially coactivates EBNA2 stimulation of the viral divergent promoter. While this may require specific transient interactions between these proteins that only occur in the context of the divergent promoter, our data strongly suggest that EBNA-LP also cooperates with EBNA2 through mechanisms that do not require direct or indirect complex formation between these proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15767449      PMCID: PMC1061541          DOI: 10.1128/JVI.79.7.4492-4505.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  85 in total

1.  Epstein-Barr virus immortalization: Notch2 interacts with CBF1 and blocks differentiation.

Authors:  J J Hsieh; D E Nofziger; G Weinmaster; S D Hayward
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

2.  Protein-protein interactions between Epstein-Barr virus nuclear antigen-LP and cellular gene products: binding of 70-kilodalton heat shock proteins.

Authors:  M K Kitay; D T Rowe
Journal:  Virology       Date:  1996-06-01       Impact factor: 3.616

3.  B-cell lines immortalized with an Epstein-Barr virus mutant lacking the Cp EBNA2 enhancer are biased toward utilization of the oriP-proximal EBNA gene promoter Wp1.

Authors:  L I Yoo; M Mooney; M T Puglielli; S H Speck
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

4.  Host-cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programs.

Authors:  B C Schaefer; J L Strominger; S H Speck
Journal:  Mol Cell Biol       Date:  1997-01       Impact factor: 4.272

5.  The Epstein-Barr virus nuclear antigen leader protein associates with hsp72/hsc73.

Authors:  J B Mannick; X Tong; A Hemnes; E Kieff
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

6.  The proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2.

Authors:  C Kaiser; G Laux; D Eick; N Jochner; G W Bornkamm; B Kempkes
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

7.  Epstein-Barr virus leader protein enhances EBNA-2-mediated transactivation of latent membrane protein 1 expression: a role for the W1W2 repeat domain.

Authors:  F Nitsche; A Bell; A Rickinson
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

8.  Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation.

Authors:  S Harada; E Kieff
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

9.  Functional replacement of the intracellular region of the Notch1 receptor by Epstein-Barr virus nuclear antigen 2.

Authors:  T Sakai; Y Taniguchi; K Tamura; S Minoguchi; T Fukuhara; L J Strobl; U Zimber-Strobl; G W Bornkamm; T Honjo
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies.

Authors:  L Szekely; K Pokrovskaja; W Q Jiang; H de The; N Ringertz; G Klein
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

View more
  20 in total

1.  EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding.

Authors:  Daniel Portal; Bo Zhao; Michael A Calderwood; Thomas Sommermann; Eric Johannsen; Elliott Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

2.  Hsp72 up-regulates Epstein-Barr virus EBNALP coactivation with EBNA2.

Authors:  Chih-Wen Peng; Bo Zhao; Hong-Chi Chen; Min-Luen Chou; Chiou-Yan Lai; Shinn-Zong Lin; Hsue-Yin Hsu; Elliott Kieff
Journal:  Blood       Date:  2007-03-06       Impact factor: 22.113

3.  The LMP1 promoter can be transactivated directly by NF-kappaB.

Authors:  Constantinos Demetriades; George Mosialos
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

4.  Crystal structure of importin-α bound to the nuclear localization signal of Epstein-Barr virus EBNA-LP protein.

Authors:  Ryohei Nakada; Yoshiyuki Matsuura
Journal:  Protein Sci       Date:  2017-04-17       Impact factor: 6.725

5.  The Epstein-Barr virus miR-BHRF1 microRNAs regulate viral gene expression in cis.

Authors:  Brigid Chiyoko Poling; Alexander M Price; Micah A Luftig; Bryan R Cullen
Journal:  Virology       Date:  2017-12       Impact factor: 3.616

6.  Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100.

Authors:  Paul D Ling; Rong Sheng Peng; Ayako Nakajima; Jiang H Yu; Jie Tan; Stephanie M Moses; Wei-Hong Yang; Bo Zhao; Elliott Kieff; Kenneth D Bloch; Donald B Bloch
Journal:  EMBO J       Date:  2005-09-22       Impact factor: 11.598

7.  Epstein-barr virus latent membrane protein 2B (LMP2B) modulates LMP2A activity.

Authors:  Mark Rovedo; Richard Longnecker
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

8.  Truncated form of the Epstein-Barr virus protein EBNA-LP protects against caspase-dependent apoptosis by inhibiting protein phosphatase 2A.

Authors:  Julie Garibal; Emilie Hollville; Andrew I Bell; Gemma L Kelly; Benjamin Renouf; Yasushi Kawaguchi; Alan B Rickinson; Joëlle Wiels
Journal:  J Virol       Date:  2007-05-09       Impact factor: 5.103

9.  Nuclear-cytoplasmic shuttling is not required for the Epstein-Barr virus EBNA-LP transcriptional coactivation function.

Authors:  Paul D Ling; Jie Tan; RongSheng Peng
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

10.  Regulation of Sp100A subnuclear localization and transcriptional function by EBNA-LP and interferon.

Authors:  Chisaroka W Echendu; Paul D Ling
Journal:  J Interferon Cytokine Res       Date:  2008-11       Impact factor: 2.607

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.